4.8 Article

Histone hyperacetylation disrupts core gene regulatory architecture in rhabdomyosarcoma

期刊

NATURE GENETICS
卷 51, 期 12, 页码 1714-+

出版社

NATURE PUBLISHING GROUP
DOI: 10.1038/s41588-019-0534-4

关键词

-

资金

  1. NCI, NIH
  2. Fondazione Veronesi fellowship
  3. Associazione Italiana Ricerca sul Cancro [AIRC 15312]
  4. Italian Ministry of Health [PE-2013-02355271]
  5. US National Institutes of Health [R01GM118653]
  6. Pershing Square Sohn Cancer Research Alliance
  7. Northwell Health Translational Research Award
  8. Christina Renna Foundation
  9. Clark Gillies Foundation
  10. Friends of T.J. Foundation
  11. Michelle Paternoster Foundation for Sarcoma Research

向作者/读者索取更多资源

Core regulatory transcription factors (CR TFs) orchestrate the placement of super-enhancers (SEs) to activate transcription of cell-identity specifying gene networks, and are critical in promoting cancer. Here, we define the core regulatory circuitry of rhabdomyosarcoma and identify critical CR TF dependencies. These CR TFs build SEs that have the highest levels of histone acetylation, yet paradoxically the same SEs also harbor the greatest amounts of histone deacetylases. We find that hyperacetylation selectively halts CR TF transcription. To investigate the architectural determinants of this phenotype, we used absolute quantification of architecture (AQuA) HiChIP, which revealed erosion of native SE contacts, and aberrant spreading of contacts that involved histone acetylation. Hyperacetylation removes RNA polymerase II (RNA Pol II) from core regulatory genetic elements, and eliminates RNA Pol II but not BRD4 phase condensates. This study identifies an SE-specific requirement for balancing histone modification states to maintain SE architecture and CR TF transcription.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Immunology

Succinate dehydrogenase/complex II is critical for metabolic and epigenetic regulation of T cell proliferation and inflammation

Xuyong Chen, Benjamin Sunkel, Meng Wang, Siwen Kang, Tingting Wang, J. N. Rashida Gnanaprakasam, Lingling Liu, Teresa A. Cassel, David A. Scott, Ana M. Munoz-Cabello, Jose Lopez-Barneo, Jun Yang, Andrew N. Lane, Gang Xin, Benjamin Z. Stanton, Teresa W. -M. Fan, Ruoning Wang

Summary: Effective T cell-mediated immune responses require proper allocation of metabolic resources and epigenetic control. Our study revealed that tricarboxylic acid cycle flux fuels biosynthetic processes and controls the ratio of succinate/alpha-ketoglutarate to modulate T cell inflammation. SDH/complex II deficiency in T cells caused proliferation and survival defects when the TCA cycle was truncated, but replenishing the nucleoside pool partially relieved the dependence of T cells on SDH/complex II. SDH deficiency induced a proinflammatory gene signature and promoted T helper 1 and T helper 17 lineage differentiation by increasing succinate/alpha-KG ratio. SDH/complex II plays a role in allocating carbon resources and epigenetic regulation in T cell proliferation and inflammation.

SCIENCE IMMUNOLOGY (2022)

Review Cell Biology

Chromatin structure in cancer

Meng Wang, Benjamin D. Sunkel, William C. Ray, Benjamin Z. Stanton

Summary: In the past decade, sequence-based methods have been used to understand chromosome organization. Advances in single molecule imaging have revealed cell-to-cell chromatin structural variation, which raises the question of whether altered chromatin structure can drive tumorigenesis. Recent studies have shown that deregulation of genome structure is characteristic in distinct classes of chromatin-driven tumors.

BMC MOLECULAR AND CELL BIOLOGY (2022)

Article Biochemistry & Molecular Biology

DNA Damage Response Gene Signature as Potential Treatment Markers for Oral Squamous Cell Carcinoma

Silvia Pomella, Matteo Cassandri, Ombretta Melaiu, Francesco Marampon, Marco Gargari, Vincenzo Campanella, Rossella Rota, Giovanni Barillari

Summary: We analyzed the genomic and transcriptomic status of DNA damage response (DDR) genes in oral squamous cell carcinoma (OSCC) and identified a signature of eight DDR genes that could predict OSCC response to antitumor compounds. Our results also showed correlations between the expression of certain DDR genes and OSCC grading and human papilloma virus infection.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Cell Biology

Spermine oxidase induces DNA damage and sensitizes fusion negative rhabdomyosarcoma cells to irradiation

Clara Perrone, Silvia Pomella, Matteo Cassandri, Michele Pezzella, Stefano Giuliani, Tecla Gasperi, Antonella Porrazzo, Anna Alisi, Anna Pastore, Silvia Codenotti, Alessandro Fanzani, Giovanni Barillari, Libenzio Adrian Conti, Biagio De Angelis, Concetta Quintarelli, Paolo Mariottini, Franco Locatelli, Francesco Marampon, Rossella Rota, Manuela Cervelli

Summary: Rhabdomyosarcoma (RMS) is a pediatric myogenic soft tissue sarcoma with two molecular subtypes, fusion-positive (FP) and fusion-negative (FN). While FP-RMS has a poor prognosis, FN-RMS shows resistance to chemotherapy and radiation therapy due to cytogenetic abnormalities and RAS pathway mutations. This study found that low expression of spermine oxidase (SMOX) is associated with worse outcomes in FN-RMS patients and is downregulated in FN-RMS cell lines. Forced expression of SMOX in high-risk FN-RMS cell lines inhibited tumor growth, induced cell cycle arrest and apoptosis, and increased DNA damage response. These findings suggest that SMOX induction could be a potential strategy to sensitize FN-RMS to ionizing radiation.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2023)

Article Hematology

A stem cell epigenome is associated with primary nonresponse to CD19 CAR T cells in pediatric acute lymphoblastic leukemia

Katherine E. Masih, Rebecca A. Gardner, Hsien-Chao Chou, Abdalla Abdelmaksoud, Young K. Song, Luca Mariani, Vineela Gangalapudi, Berkley E. Gryder, Ashley L. Wilson, Serifat O. Adebola, Benjamin Z. Stanton, Chaoyu Wang, David Milewski, Yong Yean Kim, Meijie Tian, Adam Tai -Chi Cheuk, Xinyu Wen, Yue Zhang, Gregoire Altan-Bonnet, Michael C. Kelly, Jun S. Wei, Martha L. Bulyk, Michael C. Jensen, Rimas J. Orentas, Javed Khan

BLOOD ADVANCES (2023)

Editorial Material Biochemistry & Molecular Biology

Functional Epigenomics: Pioneering Changes in Chromatin Structure

Alexi Tallan, Rachel A. Hoffman, Benjamin Z. Stanton

BIOCHEMISTRY (2023)

Review Biochemistry & Molecular Biology

The Combination of Immune Checkpoint Blockade with Tumor Vessel Normalization as a Promising Therapeutic Strategy for Breast Cancer: An Overview of Preclinical and Clinical Studies

Ombretta Melaiu, Gianluca Vanni, Ilaria Portarena, Chiara Adriana Pistolese, Lucia Anemona, Silvia Pomella, Roberto Bei, Oreste Claudio Buonomo, Mario Roselli, Alessandro Mauriello, Giovanni Barillari

Summary: Immune checkpoint inhibitors have limited clinical activity as monotherapy against breast cancer, and novel combinatorial strategies are being investigated to improve treatment response. The abnormal vasculature in breast cancer is associated with immune suppression and hampers drug delivery and immune cell trafficking. Combining immune checkpoint inhibitors with tumor vessel normalizing agents shows promise in enhancing antitumor immune responses.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Review Oncology

Genomic and Epigenetic Changes Drive Aberrant Skeletal Muscle Differentiation in Rhabdomyosarcoma

Silvia Pomella, Sara G. Danielli, Rita Alaggio, Willemijn B. Breunis, Ebrahem Hamed, Joanna Selfe, Marco Wachtel, Zoe S. Walters, Beat W. Schaefer, Rossella Rota, Janet M. Shipley, Simone Hettmer

Summary: Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma in children and adolescents, characterized by aberrant muscle differentiation. Abnormalities in the regulatory transcription factors (MRFs) involved in skeletal muscle development contribute to tumorigenesis in RMS. Core regulatory circuitries (CRCs) and hierarchically organized subsets of cells play a role in maintaining the disease-driving fusion oncogene and promoting malignancy in RMS. Understanding the genetic and epigenetic framework of abnormal muscle differentiation in RMS provides insights into its mechanisms and potential therapeutic strategies.

CANCERS (2023)

Article Biochemical Research Methods

High-throughput approaches to uncover synergistic drug combinations in leukemia

Emma J. Chory, Meng Wang, Michele Ceribelli, Aleksandra M. Michalowska, Stefan Golas, Erin Beck, Carleen Klumpp-Thomas, Lu Chen, Crystal McKnight, Zina Itkin, Kelli M. Wilson, David Holland, Sanjay Divakaran, James Bradner, Javed Khan, Berkley E. Gryder, Craig J. Thomas, Benjamin Z. Stanton

Summary: We conducted a comprehensive study on drug synergy in acute myeloid leukemia (AML), using a panel of cell lines representing different subtypes. Our study provides a valuable resource for the community, offering many unexpected synergistic drug combinations and open source code for automation and analysis. We identified drug synergies that affect the chromatin state, particularly in relation to the modification of histone H3 lysine-27. Additionally, we developed an open source high throughput methodology that allows multidimensional drug screening with widely accessible equipment.

SLAS DISCOVERY (2023)

Article Biochemistry & Molecular Biology

The 3D chromatin landscape of rhabdomyosarcoma

Meng Wang, Prethish Sreenivas, Benjamin D. Sunkel, Long Wang, Myron Ignatius, Benjamin Z. Stanton

Summary: Researchers analyzed the chromatin structure of pediatric soft tissue cancer and found that it plays a crucial role in tumor proliferation, providing insights for potential therapy options.

NAR CANCER (2023)

Article Biochemistry & Molecular Biology

A SNAI2/CTCF Interaction is Required for NOTCH1 Expression in Rhabdomyosarcoma

Prethish Sreenivas, Long Wang, Meng Wang, Anil Challa, Paulomi Modi, Nicole Rae Hensch, Berkley Gryder, Hsien-Chao Chou, Xiang R. Zhao, Benjamin Sunkel, Rodrigo Moreno-Campos, Javed Khan, Benjamin Z. Stanton, Myron S. Ignatius

Summary: RMS is a pediatric malignancy of muscle cells, and NOTCH1 is an oncogene that promotes self-renewal and blocks differentiation in RMS. The study suggests that SNAI2 and CTCF maintain a sub-topologically associating domain boundary, which promotes NOTCH1 expression. Suppression of SNAI2 results in cell loss, but a few surviving clones can re-establish NOTCH1 expression.

MOLECULAR AND CELLULAR BIOLOGY (2023)

Meeting Abstract Oncology

Multi-omic analysis identifies mechanisms of resistance to CD19 CAR T-cell therapy in children with acute lymphoblastic leukemia

Katherine E. Masih, Rebecca Gardner, Hsien-Chao Chou, Abdalla Abdelmaksoud, Young K. Song, Luca Mariani, Vineela Gangalapudi, Berkley E. Gryder, Ashley Wilson, Serifat O. Adebola, Benjamin Z. Stanton, Chaoyu Wang, Xinyu Wen, Gregoire Altan-Bonnet, Michael C. Kelly, Jun S. Wei, Martha L. Bulyk, Michael C. Jensen, Rimas J. Orentas, Javed Khan

CANCER RESEARCH (2022)

暂无数据